EMEA-001561-PIP01-13-M02
Table of contents
Key facts
| Invented name |
Alofisel
|
| Active substance |
darvadstrocel
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0026/2021
|
| PIP number |
EMEA-001561-PIP01-13-M02
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Treatment of perianal fistula
|
| Route(s) of administration |
Other use
|
| Contact for public enquiries |
Takeda Pharma A/S
Tel. +44 (0)3333000181 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|